BG60255B1 - Метод за получаване на пептиди - Google Patents

Метод за получаване на пептиди

Info

Publication number
BG60255B1
BG60255B1 BG077132A BG7713286A BG60255B1 BG 60255 B1 BG60255 B1 BG 60255B1 BG 077132 A BG077132 A BG 077132A BG 7713286 A BG7713286 A BG 7713286A BG 60255 B1 BG60255 B1 BG 60255B1
Authority
BG
Bulgaria
Prior art keywords
protein
polyhedral
vomvy
structural gene
nuclear polyhedrosis
Prior art date
Application number
BG077132A
Other languages
English (en)
Other versions
BG60255B2 (bg
Inventor
Susumu Maeda
Mitsuru Furusawa
Yasumasa Marumoto
Tadashi Horiuchi
Yoshinari Sato
Yoshiyuki Saeki
Original Assignee
Daiichi Seiyaku Co.Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co.Ltd. filed Critical Daiichi Seiyaku Co.Ltd.
Publication of BG60255B1 publication Critical patent/BG60255B1/bg
Publication of BG60255B2 publication Critical patent/BG60255B2/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/56IFN-alpha
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/65Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/14011Baculoviridae
    • C12N2710/14111Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/14011Baculoviridae
    • C12N2710/14111Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Методът намира приложение в медицината. С него се осигурява рекомбинантен вомвyх моri ядрен полихедрозисен вирус, имащ в полихедралната протеинкодираща структурна генна част на вомвyх моri ядрена полихедрозисна вирусна днк (вмnрv) и структурен ген за желан протеин, свързан към целия или към част от полихедралния протеинкодиращ структурен ген с или без вмъкване на линкерна базова последователност. Получават се кондензирани протеини на желания протеин и целият полихедрален протеин или част от него се свързва заедно с или без вмъкване на свързваща аминокиселина или пептид. 5 претенции, 8 фигури
BG77132A 1985-11-14 1986-11-14 Метод за получаване на пептиди BG60255B2 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25560785 1985-11-14

Publications (2)

Publication Number Publication Date
BG60255B1 true BG60255B1 (bg) 1994-03-24
BG60255B2 BG60255B2 (bg) 1994-03-24

Family

ID=17281082

Family Applications (1)

Application Number Title Priority Date Filing Date
BG77132A BG60255B2 (bg) 1985-11-14 1986-11-14 Метод за получаване на пептиди

Country Status (17)

Country Link
US (1) US5110729A (bg)
JP (1) JPH0797995B2 (bg)
KR (1) KR950001992B1 (bg)
CN (1) CN1032762C (bg)
AT (1) ATE82590T1 (bg)
AU (1) AU604001B2 (bg)
BG (1) BG60255B2 (bg)
CA (1) CA1294231C (bg)
DE (1) DE3687141T2 (bg)
DK (1) DK175184B1 (bg)
FI (1) FI94260C (bg)
HU (1) HU208340B (bg)
IE (1) IE59956B1 (bg)
IL (2) IL80529A0 (bg)
NO (1) NO177540C (bg)
PH (1) PH25470A (bg)
PL (1) PL158590B1 (bg)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03224491A (ja) * 1990-01-30 1991-10-03 Nippon Nousan Kogyo Kk ブタ成長ホルモン(pGH)の製造法
JPH05227967A (ja) * 1992-02-17 1993-09-07 Katakura Kogyo Kk カイコからの有用タンパク質の製造方法
CN1064405C (zh) * 1996-04-08 2001-04-11 中国农业科学院上海家畜寄生虫病研究所 利用家蚕系统生产重组日本血吸虫谷胱甘肽-转移酶
CA2257357C (en) 1996-06-07 2010-04-13 Neorx Corporation Humanized antibodies with modified glycosylation
US6613548B1 (en) 1998-07-31 2003-09-02 Pierce Biotechnology, Inc. Fusion products containing insoluble proteinaceous tag
AU2039501A (en) * 1999-10-15 2001-04-23 Rockefeller University, The System for rapid generation of recombinant baculovirus-based expression vectors for silkworm larvae
AU1600401A (en) 1999-11-12 2001-06-06 Chinese University Of Hong Kong, The Malaria vaccine
ES2411007T3 (es) 2001-10-10 2013-07-04 Novo Nordisk A/S Remodelación y glicoconjugación de péptidos
AU2003243316A1 (en) * 2002-05-24 2003-12-12 Nps Allelix Corp. Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
WO2003100022A2 (en) * 2002-05-24 2003-12-04 Restoragen, Inc. Methods and dna constructs for high yield production of polypeptides
PL1615945T3 (pl) 2003-04-09 2012-03-30 Ratiopharm Gmbh Sposoby glikopegylacji i białka/peptydy wytwarzane tymi sposobami
HRP20120315T1 (hr) * 2003-11-21 2012-05-31 Nps Pharmaceuticals Proizvodnja peptida 2 nalik glukagonu i analoga
US7736633B2 (en) * 2005-09-28 2010-06-15 E.I. Du Pont De Nemours And Company Method for enhancing effects of colorants and conditioners
JP5071740B2 (ja) * 2006-05-19 2012-11-14 国立大学法人山口大学 チョウ目昆虫用人工飼料及びその製造方法、チョウ目昆虫及びその製造方法、並びに生体物質
US7732569B2 (en) 2006-10-19 2010-06-08 E.I. Du Pont De Nemours And Company Zein-based peptide tags for the expression and purification of bioactive peptides
US20100234568A1 (en) * 2006-10-19 2010-09-16 Linda Jane Decarolis Identification of peptide tags for the production of insoluble peptides by sequence scanning
US7662913B2 (en) 2006-10-19 2010-02-16 E. I. Du Pont De Nemours And Company Cystatin-based peptide tags for the expression and purification of bioactive peptides
CN102952806B (zh) * 2012-11-13 2015-01-07 天津耀宇生物技术有限公司 多角体基因前120bp片段及其应用
CN102952805B (zh) * 2012-11-13 2015-01-07 天津耀宇生物技术有限公司 多角体基因前60bp片段及其应用
CN102952807B (zh) * 2012-11-13 2015-07-08 天津耀宇生物技术有限公司 多角体基因前180bp片段及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4745051A (en) * 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
EP0127839B1 (en) * 1983-05-27 1992-07-15 THE TEXAS A&M UNIVERSITY SYSTEM Method for producing a recombinant baculovirus expression vector
ZA848495B (en) * 1984-01-31 1985-09-25 Idaho Res Found Production of polypeptides in insect cells
JPS619288A (ja) * 1984-06-21 1986-01-16 Dai Ichi Seiyaku Co Ltd ペプチド類の製法
JPS63167797A (ja) * 1985-12-18 1988-07-11 マイクロジエネシス,インコ−ポレイテイド 選択された昆虫宿主細胞中で選択されたポリペプチドを製造する方法

Also Published As

Publication number Publication date
JPS62208276A (ja) 1987-09-12
FI864624A0 (fi) 1986-11-13
DK175184B1 (da) 2004-06-28
FI864624L (fi) 1987-05-15
CA1294231C (en) 1992-01-14
JPH0797995B2 (ja) 1995-10-25
DE3687141D1 (de) 1992-12-24
CN1032762C (zh) 1996-09-11
FI94260B (fi) 1995-04-28
HUT41845A (en) 1987-05-28
BG60255B2 (bg) 1994-03-24
NO177540B (no) 1995-06-26
NO177540C (no) 1995-10-04
DK543686A (da) 1987-05-15
PH25470A (en) 1991-07-01
DK543686D0 (da) 1986-11-13
IE862999L (en) 1987-05-14
AU6518386A (en) 1987-05-21
NO864486D0 (no) 1986-11-11
NO864486L (no) 1987-05-15
AU604001B2 (en) 1990-12-06
KR870005092A (ko) 1987-06-04
ATE82590T1 (de) 1992-12-15
PL158590B1 (pl) 1992-09-30
KR950001992B1 (ko) 1995-03-08
FI94260C (fi) 1995-08-10
DE3687141T2 (de) 1993-04-08
HU208340B (en) 1993-09-28
IE59956B1 (en) 1994-05-04
PL262348A1 (en) 1988-01-21
IL80529A0 (en) 1987-02-27
CN86107784A (zh) 1987-06-03
IL80612A (en) 1995-06-29
US5110729A (en) 1992-05-05
IL80612A0 (en) 1987-02-27

Similar Documents

Publication Publication Date Title
BG60255B1 (bg) Метод за получаване на пептиди
DE3650540D1 (de) Antigene Proteine und diese enthaltende Impfstoffe zur Verhütung von Kokzidiose
DE3588203D1 (de) Durch pre-S-Gen kodierte Hepatitis-B-Peptid-Immunogene, Vakzine, Diagnostika und synthetische Lipid-Bläschenträger
ES8800266A1 (es) Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original
ES2000278A6 (es) Procedimiento para preparar una proteina de fusion y para preparar una proteina eucariotica.
EP0339504A3 (en) Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
DE69434413D1 (de) Fusionsproteine zwischen antigene aminosäuresequenzen und beta - 2- mikroglobulin
DE69534600D1 (de) Nukleotid- und aminosäuresequenzen der gene des hüllproteins 1 und des kernproteins von hepatitis c virus
EP2044950A3 (en) Attenuated VIF DNA immunization cassettes for genetic vaccines
WO2001016163A3 (en) Peptide mixture and vaccine against a chronic viral infection
GR3007909T3 (bg)
DK595187A (da) Minactivin og fremgangsmaade til fremstilling deraf
DE59406999D1 (de) REKOMBINANTES LIESCHGRASPOLLENALLERGEN -i(Phl p) II
EP0276330A4 (de) Rekombinante plasmid-dns, kodierend für die synthese von polypeptidsubstanzen für einen impfstoff gegen hepatitis-a.
WO2001070774B1 (en) Human t cell response to mhc-binding motif clusters
Cselik DNA and protein interactions in filamentous bacteriophages
Kawai et al. Infection defense antigens against pathogenic viruses to human. Infection defense antigens and genetic code--trend and progress of study on biomolecular analysis. e. Infection defense antigens of rabies virus and genetic code
SU1380211A1 (ru) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК PUR 292 - HAV 23, КОДИРУЮЩАЯ СИНТЕЗ ГИБРИДНОГО ПОЛИПЕПТИДА АНТИГЕННЫХ ДЕТЕРМИНАНТ ВИРУСА ГЕПАТИТА А С β -ГАЛАКТОЗИДАЗОЙ
TH13136A (th) แอนติเจนของ hiv
DK362088A (da) Fusionsproteiner og fusionsproteinpartikler